Evidence map›Paper›PMID 38339038›Full record

ReviewInternational journal of molecular sciences2024

Hypoxia Sensing and Responses in Parkinson's Disease.

Johannes Burtscher, Yves Duderstadt, Hannes Gatterer, Martin Burtscher, Roman Vozdek, Grégoire P Millet, Andrew A Hicks, Hannelore Ehrenreich, Martin Kopp

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Johannes BurtscherInstitute of Sport Sciences, University of Lausanne, 1015 Lausanne, Switzerland.ORCID 0000-0002-2889-0151
Yves DuderstadtDivision of Cardiology and Angiology, University Hospital Magdeburg, 39120 Magdeburg, Germany.
Hannes GattererInstitute of Mountain Emergency Medicine, Eurac Research, 39100 Bolzano, Italy.ORCID 0000-0002-5084-2930
Martin BurtscherDepartment of Sport Science, University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-5232-3632
Roman VozdekInstitute for Biomedicine, Eurac Research, Via Alessandro Volta 21, 39100 Bolzano, Italy.ORCID 0000-0001-7691-152X
Grégoire P MilletInstitute of Sport Sciences, University of Lausanne, 1015 Lausanne, Switzerland.ORCID 0000-0001-8081-4423
Andrew A HicksInstitute for Biomedicine, Eurac Research, Via Alessandro Volta 21, 39100 Bolzano, Italy.ORCID 0000-0001-6320-0411
Hannelore EhrenreichClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, 37075 Goettingen, Germany.ORCID 0000-0001-8371-5711
Martin KoppDepartment of Sport Science, University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-3011-387X
Eurac Research · ITUniversität Innsbruck · ATUniversity of Lausanne · CHGerman Center for Neurodegenerative Diseases · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is associated with various deficits in sensing and responding to reductions in oxygen availability (hypoxia). Here we summarize the evidence pointing to a central role of hypoxia in PD, discuss the relation of hypoxia and oxygen dependence with pathological hallmarks of PD, including mitochondrial dysfunction, dopaminergic vulnerability, and alpha-synuclein-related pathology, and highlight the link with cellular and systemic oxygen sensing. We describe cases suggesting that hypoxia may trigger Parkinsonian symptoms but also emphasize that the endogenous systems that protect from hypoxia can be harnessed to protect from PD. Finally, we provide examples of preclinical and clinical research substantiating this potential.

Indexed as

Parkinson DiseaseParkinsonian Disordersalpha-SynucleinDopaminergic NeuronsHumansHypoxiaOxygenalpha-SynucleinOxygenhypoxiamitochondrianeurodegenerationParkinson’s diseaserespiratory diseasessynuclein

Identifiers

PMID38339038
PMCPMC10855464
OpenAlexW4391434094

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.